Funding of £5m will create new jobs in Norfolk

Published: 28-Jan-2010
Manufacturing Research & Development Finance Pharmaceutical

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK with £5m of funding from a partnership including the Biotechnology and Biological Sciences Research Council (BBSRC).

The new development will be based at Norwich Science Park and provide facilities for start-up and expanding businesses.

BBSRC will provide £500,000 as well as the land and buildings to host the new facilities, with £1.4m coming from the East of England Development Agency (EEDA), £1m from the Greater Norwich Development Partnership (GNDP), £500,000 from NRP partner the University of East Anglia (UEA), and the remainder from other NRP partners.

The new facilities, to be opened in July, will be managed by a new joint venture company called Colney Innovations (CIL).

David Parfrey, BBSRC director of finance and director of CIL, said: "The research carried out by the 2,000 scientists already working at Norwich Science Park is world-class and it makes absolute sense to create a facility on this site where the results of such research can be taken through to applications."

Prof Douglas Kell, chief executive of BBSRC, added: "The Norwich Research Park is home to three world-class BBSRC institutes: the John Innes Centre, the Institute of Food Research and The Genome Analysis Centre. This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products to benefit the economy and people of the UK."




See more

You may also like

Research & Development

Merck and Moderna announce 5-year data for intismeran autogene in combination with KEYTRUDA

Read more
Eight Phase II and Phase III clinical trials are under way across multiple tumour types, including melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma

Trending Articles

  1. IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
  2. FDA and EMA issue guiding principles for AI in drug development The set of ten principles gives broad guidance on AI use in evidence generation and monitoring across all phases of a medicine, from early research and clinical trials to manufacturing and safety monitoring
  3. Enara Bio expands Boehringer Ingelheim partnership as DARKFOX programme moves toward the clinic Enara Bio has entered 2026 with renewed momentum after Boehringer Ingelheim licensed additional Dark Antigen targets under their oncology collaboration. The company is also continuing to expand its EDAPT discovery platform
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Miniaturisation in medtech: mechanical factors that influence product success Medical devices are becoming smaller, lighter and more portable. From handheld diagnostic tools to wearable infusion pumps and compact surgical instruments, reduced size is now a defining feature of many new medtech products
  5. Thermo Fisher unveils HepatoExpress kit for liver cell gene expression analysis The new Invitrogen TaqMan Cells-to-CT HepatoExpress Kit eliminates the need for traditional RNA purification, streamlining workflows and reducing time to results and offers less plastic waste compared to traditional RNA purification methods

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

You may also like

Research & Development

Merck and Moderna announce 5-year data for intismeran autogene in combination with KEYTRUDA

Eight Phase II and Phase III clinical trials are under way across multiple tumour types, including melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma
Manufacturing

OMRON introduces new high-payload collaborative robots and TMflow software upgrade

OMRON unveils advanced collaborative robots and upgraded TMflow software to boost manufacturing flexibility and productivity
Manufacturing

Sharp Services invests more than €20m to expand injectables packaging capacity at its European facilities

Expansion includes significant cold chain warehouse capacity to support injectable formats
Manufacturing

Key drivers behind the rise of microsphere drug delivery systems

Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends
Manufacturing

Inside the shift toward greener, faster, Smarter drug manufacturing

Dave Henderson, Ph.D, MBA, Head of R&D Labs at Asymchem explores the pharmaceutical manufacturing landscape and the challenges CDMOs must address to remain competitive in this shifting market
Finance

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), announces the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035
Manufacturing

Onyx Scientific boosts solid form and particle engineering capabilities

Marking its 25th anniversary, Onyx Scientific has invested in new crystallisation, particle imaging and processing technologies to accelerate development of complex molecules across early and late stages
Subscribe now